News
Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
6d
New Scientist on MSNDrugs like Ozempic and Wegovy could significantly cut dementia riskDozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...
As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...
Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...
Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...
CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...
11d
Verywell Health on MSNContrave vs. Wegovy: How Do They Compare for Weight Loss?Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...
6don MSN
Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...
In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...
Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new ...
A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results